申请人:BASF Aktiengesellschaft
公开号:US04564641A1
公开(公告)日:1986-01-14
1-Oxo-2-phenyl-2-(2-alkylaminoethyl)-1,2,3,4-tetrahydronaphthalenes of the formula I ##STR1## where R.sup.1 and R.sup.2 are identical or different and are each hydrogen, halogen, trifluoromethyl, C.sub.1 -C.sub.4 -alkyl or C.sub.1 -C.sub.4 -alkoxy, R.sup.3 is C.sub.1 -C.sub.6 -alkyl and R.sup.4 is hydrogen, C.sub.1 -C.sub.6 -alkyl or benzyl, or R.sup.3 and R.sup.4 together may furthermore be a C.sub.2 -C.sub.5 -alkylene chain, and their salts with physiologically tolerated acids, and their preparation, are described. The novel compounds are useful active compounds for treating disorders.
式I中,R1和R2相同或不同,可以是氢、卤素、三氟甲基、C1-C4烷基或C1-C4烷氧基;R3为C1-C6烷基,R4为氢、C1-C6烷基或苄基,或R3和R4还可以是C2-C5烷基链,以及它们与生理耐受酸的盐和制备方法都被描述了。这些新化合物是治疗疾病的有用活性化合物。